Literature DB >> 23344283

Factors associated with 12-month discontinuation among contraceptive pill, patch, and ring users.

Jourdan E Stuart1, Gina M Secura, Qiuhong Zhao, Meredith E Pittman, Jeffrey F Peipert.   

Abstract

OBJECTIVE: To examine factors associated with discontinuation of the oral contraceptive pill (OCP), patch, and ring.
METHODS: We included 1,452 female participants from the Contraceptive CHOICE Project who selected the OCP, patch, or ring and completed 12 months of follow-up for this analysis. We defined discontinuation as stopping the contraceptive method for longer than 1 month during a follow-up survey. Participants who stopped their method as a result of pregnancy or to attempt pregnancy or who were lost to follow-up were censored. We examined demographic, behavioral, and method-related factors in the Cox proportional hazard models.
RESULTS: Patch users had a higher 1-year discontinuation rate (58%) than OCP (47%; P=.03) and ring users (49%; P=.02). Women were more likely to discontinue the OCP, patch, or ring if they were black (adjusted hazard ratio [HR] 1.21, 95% confidence interval [CI] 1.02-1.44), no longer married (adjusted HR 1.83, 95% CI 1.27-2.65), or received public assistance (adjusted HR 1.30, 95% CI 1.08-1.57). Women who reported difficulty obtaining the method were more than twice as likely to discontinue (adjusted HR 2.43, 95% CI 1.81-3.27). Women who were certain they would continue despite side effects (adjusted HR 0.57, 95% CI 0.43-0.77) were less likely to discontinue.
CONCLUSION: Despite selecting their method and obtaining it at no cost, almost half of OCP and ring users and a majority of patch users discontinued their method by 12 months. Experiencing difficulty obtaining the method contributes to high rates of discontinuation. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23344283     DOI: 10.1097/AOG.0b013e31827e5898

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  15 in total

1.  Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants.

Authors:  Rebecca G Simmons; Jessica N Sanders; Claudia Geist; Lori Gawron; Kyl Myers; David K Turok
Journal:  Am J Obstet Gynecol       Date:  2018-12-18       Impact factor: 8.661

Review 2.  Implementation challenges for long-acting antivirals as treatment.

Authors:  Diane Havlir; Monica Gandhi
Journal:  Curr Opin HIV AIDS       Date:  2015-07       Impact factor: 4.283

Review 3.  Biomaterials and Contraception: Promises and Pitfalls.

Authors:  Isabella Claure; Deborah Anderson; Catherine M Klapperich; Wendy Kuohung; Joyce Y Wong
Journal:  Ann Biomed Eng       Date:  2019-11-07       Impact factor: 3.934

4.  Pharmacy claims data versus patient self-report to measure contraceptive method continuation.

Authors:  Jourdan E Triebwasser; Stephanie Higgins; Gina M Secura; Qiuhong Zhao; Jeffrey F Peipert
Journal:  Contraception       Date:  2015-04-07       Impact factor: 3.375

5.  Oral contraceptive use and psychiatric disorders in a nationally representative sample of women.

Authors:  Keely Cheslack-Postava; Katherine M Keyes; Sarah R Lowe; Karestan C Koenen
Journal:  Arch Womens Ment Health       Date:  2014-08-13       Impact factor: 3.633

6.  Highly Effective Birth Control Use Before and After Women's Incarceration.

Authors:  Megha Ramaswamy; Hsiang-Feng Chen; Karen L Cropsey; Jennifer G Clarke; Patricia J Kelly
Journal:  J Womens Health (Larchmt)       Date:  2015-01-02       Impact factor: 2.681

7.  Sporadic contraceptive use and nonuse: age-specific prevalence and associated factors.

Authors:  Karen Pazol; Maura K Whiteman; Suzanne G Folger; Athena P Kourtis; Polly A Marchbanks; Denise J Jamieson
Journal:  Am J Obstet Gynecol       Date:  2014-10-08       Impact factor: 8.661

8.  Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices.

Authors:  Dirk Wildemeersch; Ansgar Pett; Sohela Jandi; Thomas Hasskamp; Patrick Rowe; Marc Vrijens
Journal:  Int J Womens Health       Date:  2013-04-30

Review 9.  Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.

Authors:  Andrea Ries Thurman; Meredith R Clark; Jennifer A Hurlburt; Gustavo F Doncel
Journal:  Int J Womens Health       Date:  2013-10-21

Review 10.  Family planning counseling for women living with HIV: a systematic review of the evidence of effectiveness on contraceptive uptake and pregnancy incidence, 1990 to 2011.

Authors:  Kevin R O'Reilly; Caitlin E Kennedy; Virginia A Fonner; Michael D Sweat
Journal:  BMC Public Health       Date:  2013-10-08       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.